[go: up one dir, main page]

ZA200902048B - Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione - Google Patents

Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione

Info

Publication number
ZA200902048B
ZA200902048B ZA200902048A ZA200902048A ZA200902048B ZA 200902048 B ZA200902048 B ZA 200902048B ZA 200902048 A ZA200902048 A ZA 200902048A ZA 200902048 A ZA200902048 A ZA 200902048A ZA 200902048 B ZA200902048 B ZA 200902048B
Authority
ZA
South Africa
Prior art keywords
ione
quinazolin
piperazin
indol
pyrrole
Prior art date
Application number
ZA200902048A
Other languages
English (en)
Inventor
Piotr Karpinski
Stephanie Monnier
Elias Ndzie
Dimitris Papoutsakis
Paul Allen Sutton
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38921707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200902048(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200902048B publication Critical patent/ZA200902048B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200902048A 2006-10-20 2009-03-24 Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione ZA200902048B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85338406P 2006-10-20 2006-10-20

Publications (1)

Publication Number Publication Date
ZA200902048B true ZA200902048B (en) 2010-01-27

Family

ID=38921707

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902048A ZA200902048B (en) 2006-10-20 2009-03-24 Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione

Country Status (23)

Country Link
US (1) US8865897B2 (xx)
EP (1) EP2102195A1 (xx)
JP (1) JP5302199B2 (xx)
KR (1) KR20090073231A (xx)
CN (2) CN101522664B (xx)
AR (1) AR063491A1 (xx)
AU (1) AU2007309558B2 (xx)
BR (1) BRPI0717461A2 (xx)
CA (1) CA2666965A1 (xx)
CL (1) CL2007003006A1 (xx)
EC (1) ECSP099344A (xx)
IL (1) IL197962A (xx)
MA (1) MA30886B1 (xx)
MX (1) MX2009004048A (xx)
MY (1) MY158026A (xx)
NO (1) NO20091970L (xx)
NZ (1) NZ576241A (xx)
PE (1) PE20081133A1 (xx)
RU (1) RU2481341C2 (xx)
TN (1) TN2009000147A1 (xx)
TW (1) TWI399374B (xx)
WO (1) WO2008051440A1 (xx)
ZA (1) ZA200902048B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090118110A (ko) * 2007-03-09 2009-11-17 노파르티스 아게 3-(1ｈ-인돌-3-일)-4-[2-(4-메틸-피페라진-1-일)-퀴나졸린-4-일]-피롤-2,5-디온의 염
US9005409B2 (en) 2011-04-14 2015-04-14 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9017528B2 (en) 2011-04-14 2015-04-28 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9303329B2 (en) 2013-11-11 2016-04-05 Tel Nexx, Inc. Electrochemical deposition apparatus with remote catholyte fluid management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2329263C2 (ru) * 2000-11-07 2008-07-20 Новартис Аг Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с
GB0504203D0 (en) * 2005-03-01 2005-04-06 Novartis Ag Organic compounds
MY148901A (en) 2007-06-18 2013-06-14 Sanofi Aventis Pyrrole derivatives as p2y12 antagonists

Also Published As

Publication number Publication date
NZ576241A (en) 2012-05-25
PE20081133A1 (es) 2008-09-16
KR20090073231A (ko) 2009-07-02
NO20091970L (no) 2009-05-20
RU2481341C2 (ru) 2013-05-10
AU2007309558B2 (en) 2012-05-24
IL197962A (en) 2013-08-29
CA2666965A1 (en) 2008-05-02
ECSP099344A (es) 2009-06-30
MX2009004048A (es) 2009-04-27
CN101522664A (zh) 2009-09-02
EP2102195A1 (en) 2009-09-23
BRPI0717461A2 (pt) 2013-10-08
RU2009118816A (ru) 2010-11-27
TN2009000147A1 (en) 2010-10-18
AU2007309558A1 (en) 2008-05-02
MA30886B1 (fr) 2009-11-02
CN103265533A (zh) 2013-08-28
TWI399374B (zh) 2013-06-21
MY158026A (en) 2016-08-30
CL2007003006A1 (es) 2008-05-23
US8865897B2 (en) 2014-10-21
IL197962A0 (en) 2009-12-24
WO2008051440A1 (en) 2008-05-02
AR063491A1 (es) 2009-01-28
TW200829572A (en) 2008-07-16
JP2010506927A (ja) 2010-03-04
CN101522664B (zh) 2013-06-12
JP5302199B2 (ja) 2013-10-02
US20100041884A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
IL177283A0 (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
AU2007261442B2 (en) Adjustable orthotic
EP3150120B8 (de) Orthopädisches interface
EP2005764A4 (en) CORRECTION OF A VERTICAL ENVIRONMENTAL PARALLAX
SI2049500T1 (sl) Ciklopenta (d) pirimidini kot AKT protein kinazni inhibitorji
IL205086A0 (en) Indexable insert
EP2089810A4 (en) SOLICITATION TRANSFORMATIONS FOR RELATIONSHIP OF CONFIDENCE
EP2061470A4 (en) HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES
ZA200902048B (en) Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione
IL194388A0 (en) Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma vaccination
GB0405985D0 (en) Kinase
HK1132506A (en) Crystal modifications -3-(1h-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione
GB2428195B (en) Patient stability aid
GB0504249D0 (en) Heating insole
AU2007901022A0 (en) Orthotic insert
TWM300526U (en) Correction insoles
AU2007902932A0 (en) Orthotic Footwear
GB0609357D0 (en) Tiling aids
GB0612600D0 (en) Tiling aids
HK1093418B (en) Improved bunion cushion
GB0701525D0 (en) Raised levelling aids
AU2008902799A0 (en) Orthotic Footwear
AU2008906650A0 (en) Quinazolinone compounds
GB0427555D0 (en) Bed patch
AU2006905382A0 (en) Medical First Aid Vending Machine